Breaking News Instant updates and real-time market news.

NVO

Novo Nordisk

$47.31

0.43 (0.92%)

06:07
08/14/18
08/14
06:07
08/14/18
06:07

Novo Nordisk management to meet with Morgan Stanley

Meeting to be held in New York on August 14 hosted by Morgan Stanley.

  • 14

    Aug

  • 25

    Aug

NVO Novo Nordisk
$47.31

0.43 (0.92%)

04/05/18
RHCO
04/05/18
NO CHANGE
Target $101
RHCO
Buy
Eli Lilly supported by positive oncology and diabetes findings, says SunTrust
SunTrust analyst John Boris keeps his Buy rating and $101 price target on Eli Lilly (LLY), citing the latest developments in Oncology and Diabetes. In Oncology, Boris points to the positive Overall Survival and Progression Free Survival data for Cyramza in second-line hepatocellular carcinoma, though he sees the commercial opportunity in Hepatocellular Carcinoma as limited. In Diabetes, the analyst points to the latest data showing Trulicity gaining market share on Novo Nordisk's (NVO) Victoza in the GLP-1 market.
06/01/18
ROTH
06/01/18
NO CHANGE
Target $400
ROTH
Buy
Roth Capital ups Madrigal price target to $400, examines possible M&A scenarios
Roth Capital analyst Yasmeen Rahimi noted that Madrigal Pharmaceuticals' (MDGL) "impressive" NASH resolution results published yesterday resulted in the stock's value being pushed up to make it the highest among "purely NASH" companies. Among large pharma companies, Rahimi believes those with the strongest metabolic franchises, large R&D teams, and sales forces focused on endocrinologists, gastroenterologists, and hepatologists likely have eyes on NASH assets, listing Merck (MRK), AstraZeneca (AZN), Eli Lilly (LLY) and Novo Nordisk (NVO) as examples. The historical acquisition price for NASH assets ranges from $200M to $1.7B, but Rahimi argues that Madrigal "can set the highest NASH price tag yet," estimating a potential takeout valuation of $5.6B. Rahimi raised her price target on Madrigal shares to $400 from $210 and keeps a Buy rating on the stock.
07/02/18
BERN
07/02/18
UPGRADE
BERN
Outperform
Novo Nordisk upgraded to Outperform from Market Perform at Bernstein
07/19/18
BMOC
07/19/18
NO CHANGE
Target $80
BMOC
Market Perform
Eli Lilly to have a 'good Q2' on beats from launch franchises, says BMO Capital
BMO Capital analyst Alex Arfaei raised his price target on Eli Lilly to $80 from $78 ahead of its Q2 earnings, saying the company will have a "good" quarter on "beats from its launch franchises Trulicity, Jardiance, and Basaglar". The analyst also keeps his Market Perform rating, adding that while the the pipeline potential of its Galcanezumab and Tanezumab drugs is promising, he believes investors are underappreciating the headwinds around its diabetes program. He see higher risks of an increased biosimilar erosion for Humalog from Sanofi's (SNY) Admelog, and Trulicity competitive pressure from Novo's (NVO) Ozempic in 2019.

TODAY'S FREE FLY STORIES

RYB

RYB Education

$6.05

-0.08 (-1.31%)

05:36
12/18/18
12/18
05:36
12/18/18
05:36
Hot Stocks
RYB Education announces $12M share repurchase program »

RYB Education announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$45.72

-0.9 (-1.93%)

05:32
12/18/18
12/18
05:32
12/18/18
05:32
Recommendations
Oracle analyst commentary  »

Oracle Q2 results a step…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDAQ

Nasdaq

$85.19

-1.3 (-1.50%)

05:30
12/18/18
12/18
05:30
12/18/18
05:30
Hot Stocks
Nasdaq raises offer for proposed acquisition of Cinnober to SEK 87 per share »

On September 14, Nasdaq…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRH

DiamondRock

$9.58

-0.33 (-3.33%)

05:27
12/18/18
12/18
05:27
12/18/18
05:27
Downgrade
DiamondRock rating change  »

DiamondRock downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YNDX

Yandex

$27.49

-0.52 (-1.86%)

05:27
12/18/18
12/18
05:27
12/18/18
05:27
Hot Stocks
Yandex to acquire property site for new Moscow headquarters »

Yandex announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHO

Sunstone Hotel

$14.08

-0.32 (-2.22%)

05:23
12/18/18
12/18
05:23
12/18/18
05:23
Downgrade
Sunstone Hotel rating change  »

Sunstone Hotel downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HST

Host Hotels

$17.31

-0.46 (-2.59%)

05:21
12/18/18
12/18
05:21
12/18/18
05:21
Upgrade
Host Hotels rating change  »

Host Hotels upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$64.86

-0.78 (-1.19%)

, S

Sprint

$5.83

-0.14 (-2.35%)

05:18
12/18/18
12/18
05:18
12/18/18
05:18
Hot Stocks
T-Mobile, Sprint receives approval from CFIUS, Team Telecom »

T-Mobile (TMUS) and…

TMUS

T-Mobile

$64.86

-0.78 (-1.19%)

S

Sprint

$5.83

-0.14 (-2.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPG

Washington Prime

$5.76

-0.38 (-6.19%)

05:18
12/18/18
12/18
05:18
12/18/18
05:18
Downgrade
Washington Prime rating change  »

Washington Prime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBHS

Fortune Brands

$39.62

-0.76 (-1.88%)

05:16
12/18/18
12/18
05:16
12/18/18
05:16
Downgrade
Fortune Brands rating change  »

Fortune Brands downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

05:15
12/18/18
12/18
05:15
12/18/18
05:15
General news
FX Action: USD-JPY extended losses »

FX Action: USD-JPY…

SNDR

Schneider National

$19.12

-0.015 (-0.08%)

05:11
12/18/18
12/18
05:11
12/18/18
05:11
Downgrade
Schneider National rating change  »

Schneider National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSC

Norfolk Southern

$147.63

-3.18 (-2.11%)

05:11
12/18/18
12/18
05:11
12/18/18
05:11
Upgrade
Norfolk Southern rating change  »

Norfolk Southern upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$95.83

-0.86 (-0.89%)

05:10
12/18/18
12/18
05:10
12/18/18
05:10
Downgrade
Kansas City Southern rating change  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCOI

Cogent

$45.37

-1.25 (-2.68%)

05:07
12/18/18
12/18
05:07
12/18/18
05:07
Upgrade
Cogent rating change  »

Cogent upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLD

Prologis

$61.50

-2.81 (-4.37%)

05:05
12/18/18
12/18
05:05
12/18/18
05:05
Upgrade
Prologis rating change  »

Prologis upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLNXF

Cellnex

$0.00

(0.00%)

05:02
12/18/18
12/18
05:02
12/18/18
05:02
Downgrade
Cellnex rating change  »

Cellnex downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXST

Nexstar

$84.01

-1 (-1.18%)

, TRCO

Tribune Media

$45.33

-0.04 (-0.09%)

05:00
12/18/18
12/18
05:00
12/18/18
05:00
Recommendations
Nexstar, Tribune Media analyst commentary  »

Nexstar price target…

NXST

Nexstar

$84.01

-1 (-1.18%)

TRCO

Tribune Media

$45.33

-0.04 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$13.46

-0.84 (-5.87%)

04:56
12/18/18
12/18
04:56
12/18/18
04:56
Initiation
Tailored Brands initiated  »

Tailored Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASOMY

Asos

$0.00

(0.00%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Downgrade
Asos rating change  »

Asos downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIRG

Airgain

$10.70

-0.55 (-4.89%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Airgain management to meet with William Blair »

Luncheon Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

CSTM

Constellium

$7.86

0.15 (1.95%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Constellium management to meet with Morgan Stanley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

SMLR

Semler Scientific

$0.00

(0.00%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Semler Scientific management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 07

    Jan

HSII

Heidrick & Struggles

$32.08

-1.43 (-4.27%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Heidrick & Struggles management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

ALSN

Allison Transmission

$42.98

-0.33 (-0.76%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Allison Transmission management to meet with Buckingham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.